ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Modulatory effect of berberine and its risk assessment during pre-natal and post-natal exposure of nicotine.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lactational exposure to polystyrene nanoplastics induces oxidative stress, testicular histological alterations, and impaired sperm quality in rat offspring.Histochemistry and cell biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nicotine is a naturally occurring alkaloid that has deleterious effects on the female reproductive system while, berberine is an isoquinoline alkaloid reported to exhibit multiple pharmacological properties. This study was conducted to analyze the role of berberine on pre and post-natal toxic effects of nicotine on mothers and pups. Nicotine was administered subcutaneously while berberine was administered orally to adult female Wister rats. Animals were divided into seven groups, with each group containing ten females. For the pre-mating phase, treatments were given daily for 30 days; after 20 days of dosing, females were housed with males for mating, and dosing continued for the remaining 10 days. Group I served as the control and received 0.5% carboxymethylcellulose (CMC) orally. Group II received nicotine alone (1 mg/kg, subcutaneously) from gestational day 0 (GD0) to GD21. Groups III and IV received nicotine (1 mg/kg, subcutaneously) combined with berberine at 10 mg/kg and 20 mg/kg orally, respectively, from GD0 to GD21. Group V received nicotine (1 mg/kg) starting 20 days before mating and continuing through GD21. Groups VI and VII received nicotine (1 mg/kg, subcutaneously) along with berberine at 10 mg/kg and 20 mg/kg (orally), respectively, beginning 20 days before mating and continuing through gestation. Berberine showed protective effects at lower doses by normalizing key antioxidant biomarkers like superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH), higher doses can exacerbate oxidative stress, as indicated by increased levels of malondialdehyde (MDA), a marker of oxidative damage. The results from the current study showed that berberine might have protective effects in other conditions but the dose-dependent toxicity highlights the potential risks of berberine, especially during pregnancy, where its ability to induce uterine contractions and teratogenic effects at higher doses poses significant concerns for fetal health.
Indexed as
Identifiers
41148254What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.